ThinkCyte Inc.: ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.
Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)
SAN DIEGO, CA and SOUTH SAN FRANCISCO, CA / / January 21, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ('Dermata') and Revance Therapeutics, Inc. (Nasdaq: RVNC) ('Revance' together ...
Hosted on MSN7d
Theranos Broke Rules That This Blood Test Company Vows to Live By
It was quick, and afterward, I donned a Band-Aid with the Truvian logo. In the next room ... He is the chief of the clinical chemistry laboratory at San Francisco General Hospital and chief of the ...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
Detailed price information for Tenon Medical Inc (TNON-Q) from The Globe and Mail including charting and trades.
BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for infringement of European patent EP 3 175 863 B1 at the Unified ...
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...
Databricks Announces $15B in Financing to Attract Top AI Talent and Accelerate Global Expansion
Data intelligence leader completes $10B Series J and closes additional $5.25B debt financing SAN FRANCISCO, Jan. 22, 2025 /PRNewswire/ -- Databricks, the Data and AI company, today announced ...
Sana Biotechnology, Inc. (SANA): A Bull Case Theory
We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025?
We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...